Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 94%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,666
Total Claims
$1.3M
Drug Cost
636
Beneficiaries
$1,992
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-26%
Opioid rate vs peers
1.9% vs 2.6% avg
+87%
Cost per patient vs peers
$1,992 vs $1,068 avg
+15%
Brand preference vs peers
10.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.9%
Opioid Rate
298
Opioid Claims
$11K
Opioid Cost
5.4%
Long-Acting Rate
Brand vs Generic
Brand: 1,605 claims · $949K
Generic: 13,946 claims · $306K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 104 | $145K |
| Apixaban | 187 | $132K |
| Rivaroxaban | 86 | $59K |
| Insulin Glargine,hum.Rec.Anlog | 42 | $43K |
| Sitagliptin Phosphate | 40 | $36K |
| Dulaglutide | 24 | $34K |
| Mirabegron | 52 | $31K |
| Fluticasone/Umeclidin/Vilanter | 30 | $25K |
| Insulin Aspart | 29 | $23K |
| Insulin Degludec | 20 | $23K |
| Empagliflozin | 19 | $20K |
| Fluticasone/Vilanterol | 32 | $17K |
| Gabapentin | 404 | $11K |
| Dexlansoprazole | 23 | $11K |
| Insulin Detemir | 11 | $9,720 |
Prescribing Profile
Patient Profile
73
Avg Age
54%
Female
1.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About